Abingdon, United Kingdom

Ian Yule

This inventor holds 5 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Breakpoint Therapeutics Gmbh, Blacksmith Medicines, Inc., Forge Therapeutics, Inc.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian Yule. Retrieved from https://idiyas.com/inventor/ian-yule-hzs7qwtf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.5

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ian Yule: Pioneering Antibacterial and Modulatory Research

Introduction: Ian Yule is an accomplished inventor based in Abingdon, Great Britain, known for his contributions to the field of pharmaceuticals. With a remarkable portfolio of patents, Yule's inventions focus on the development of compounds that target and inhibit harmful bacteria as well as important modulators of human health.

Latest Patents: Ian Yule holds two notable patents. The first patent involves antibacterial compounds, specifically heterocyclic derivative compounds of Formula (II). These compounds are designed to inhibit the growth of gram-negative bacteria, making them valuable in treating bacterial infections, including urinary tract infections. The second patent is centered around fused imidazole and pyrazole derivatives, which serve as potent modulators of tumor necrosis factor (TNF) activity. This series of compounds has significant applications in the treatment and prevention of various human ailments such as autoimmune disorders, neurological conditions, cardiovascular issues, and oncological disorders.

Career Highlights: Yule has made significant strides in his career, collaborating with prominent companies in the biopharmaceutical industry. Notable among these are UCB Biopharma, an established leader in biopharma, and Forge Therapeutics, Inc., where he leveraged his expertise to drive innovative research and development efforts.

Collaborations: Throughout his journey, Ian Yule has collaborated with talented coworkers such as Rikki Peter Alexander and Jonathan Bentley. These partnerships have further enriched his work, combining diverse perspectives and expertise to advance their shared goals in innovation.

Conclusion: Ian Yule's work exemplifies the power of innovation in medicine. With his focused patents on antibacterial and modulatory compounds, he strengthens the arsenal available for fighting bacterial infections and various health disorders. His contributions serve as an inspiration for future inventors and researchers aiming to make a difference in the pharmaceutical landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…